Clinical Trial Update: Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating a combination of sacituzumab govitecan with capecitabine in advanced gastrointestinal cancers after progression on standard the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Henry Ford Health System | Conditions: Gastrointestinal Cancer | Phase 1 | Status: RECRUITING